Unknown

Dataset Information

0

Depletion of major pathogenic cells in asthma by targeting CRTh2.


ABSTRACT: Eosinophilic inflammation and Th2 cytokine production are central to the pathogenesis of asthma. Agents that target either eosinophils or single Th2 cytokines have shown benefits in subsets of biomarker-positive patients. More broadly effective treatment or disease-modifying effects may be achieved by eliminating more than one inflammatory stimulator. Here we present a strategy to concomitantly deplete Th2 T cells, eosinophils, basophils, and type-2 innate lymphoid cells (ILC2s) by generating monoclonal antibodies with enhanced effector function (19A2) that target CRTh2 present on all 4 cell types. Using human CRTh2 (hCRTh2) transgenic mice that mimic the expression pattern of hCRTh2 on innate immune cells but not Th2 cells, we demonstrate that anti-hCRTh2 antibodies specifically eliminate hCRTh2+ basophils, eosinophils, and ILC2s from lung and lymphoid organs in models of asthma and Nippostrongylus brasiliensis infection. Innate cell depletion was accompanied by a decrease of several Th2 cytokines and chemokines. hCRTh2-specific antibodies were also active on human Th2 cells in vivo in a human Th2-PBMC-SCID mouse model. We developed humanized hCRTh2-specific antibodies that potently induce antibody-dependent cell cytotoxicity (ADCC) of primary human eosinophils and basophils and replicated the in vivo depletion capacity of their murine parent. Therefore, depletion of hCRTh2+ basophils, eosinophils, ILC2, and Th2 cells with h19A2 hCRTh2-specific antibodies may be a novel and more efficacious treatment for asthma.

SUBMITTER: Huang T 

PROVIDER: S-EPMC5033936 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


Eosinophilic inflammation and Th2 cytokine production are central to the pathogenesis of asthma. Agents that target either eosinophils or single Th2 cytokines have shown benefits in subsets of biomarker-positive patients. More broadly effective treatment or disease-modifying effects may be achieved by eliminating more than one inflammatory stimulator. Here we present a strategy to concomitantly deplete Th2 T cells, eosinophils, basophils, and type-2 innate lymphoid cells (ILC2s) by generating mo  ...[more]

Similar Datasets

| S-EPMC5529497 | biostudies-literature
| S-EPMC5651193 | biostudies-other
| S-EPMC5914763 | biostudies-literature
| S-EPMC5021787 | biostudies-literature
| S-EPMC5012601 | biostudies-literature
| S-EPMC1810525 | biostudies-literature
| S-EPMC4936908 | biostudies-literature
| S-EPMC6047040 | biostudies-literature
| S-EPMC3400080 | biostudies-other
2013-01-11 | E-GEOD-31030 | biostudies-arrayexpress